October 7-9, 2024
Join us at Meeting on the Mesa 2024
We’re excited to connect with you at the 2024 Cell & Gene Meeting on the Mesa this October. It’s an incredible opportunity to come together with other industry experts to address the challenges and advancements in cell and gene therapies, and Cencora is a diamond sponsor this year.
October 7, 2024 3:00-3:45 PDT | FLW Ballroom
Navigating the path to success: Commercializing cell and gene therapies in today’s dynamic market
Join our panel discussion chaired by Whitney Ijem, Managing Director and Senior Biotechnology Analyst at Canaccord Genuity and featuring speakers Warner Biddle, Senior Vice President and Global Head of Commercial at Kite, and Lung-I Cheng, Vice President and Head of Cell and Gene Therapy at Cencora.
Resources
- Unlocking healthier futures with cell and gene therapy | Click here to view
- Insights and learnings to drive CGT access forward | Click here to view
- Global ATMP charging stations | Click here to view
- Getting investigational medicinal products to the patient | Click here to view
- Bringing hope with delivery of gene therapy to Freya | Click here to view
- What to consider when shipping your specialty drug | Click here to view
Cell and gene therapy solutions
Enable connections across the CGT journey
As healthcare advances, so must the processes that connect patients to the therapies they need. Each patient's path to treatment is unique. And because a rapidly evolving cell therapy market requires an equally innovative partner, we are committed to delivering solutions that enable this connection.
Optimize decision-making and reduce costs
Cencora offers comprehensive support throughout the biotech journey, from early discovery to clinical development. Our experts leverage extensive global experience to create a holistic "bench-to-bedside" approach that can minimize risk and improve the likelihood of successful product market entry.
Transforming cell and gene therapy supply chain management
TrakCel is the leading provider of cellular orchestration solutions for the global cell and gene therapy industry. Their innovative software, OCELLOS, simplifies and connects every stakeholder in the therapy supply chain - for both clinical and commercial products. With real-time tracking of Chain of Identity (COI) and Chain of Custody (COC), automated notifications, and seamless integration of data from multiple sources, OCELLOS ensures end-to-end visibility and security. Trusted by over 200 sites worldwide, OCELLOS is already empowering thousands of users.